Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Somatostatin: physiological and clinical significance.

Guillemin R, Gerich JE.

Annu Rev Med. 1976;27:379-88. Review. No abstract available.

PMID:
779605
2.

Somatostatin.

Efendić S, Hökfelt T, Luft R.

Adv Metab Disord. 1978;9:367-424. Review. No abstract available.

PMID:
347908
3.

Somatostatin, basic and clinical studies. A review.

Schally AV, Meyers CA.

Mater Med Pol. 1980 Jan-Jun;12(1-2):28-32. Review. No abstract available.

PMID:
6120265
4.

Somatostatin: diabetes and acromegaly.

Gerich JE.

Adv Intern Med. 1977;22:251-72. Review. No abstract available.

PMID:
190870
5.

Clinical implications of growth hormone release inhibiting hormone (GH-RIH).

Besser GM.

Curr Top Mol Endocrinol. 1976;3:115-25. Review. No abstract available.

PMID:
211004
6.

[Somatostatin].

Tragl KH.

Acta Med Austriaca. 1978;5(3):80-4. Review. German.

PMID:
377888
7.

Somatostatin and diabetes.

Gerich JE.

Am J Med. 1981 Mar;70(3):619-26. Review.

PMID:
6111219
8.

[Somatostatin--a hypothalamic factor inhibiting the secretion of growth hormone].

Lankosz-Lauterbach J.

Pediatr Pol. 1977 Aug;52(8):919-23. Review. Polish. No abstract available.

PMID:
333364
9.

[The role of somatostatin in diabetic disease].

Leonardi R, Toffoli C, Rigamonti D, Rigamonti L.

Arch Sci Med (Torino). 1981 Jan-Mar;138(1):11-5. Review. Italian. No abstract available.

PMID:
6113823
10.

Somatostatin and the endocrine pancreas.

Gerich JE.

Curr Top Mol Endocrinol. 1976;3:127-43. Review.

PMID:
211005
11.

Somatostatin: a review of its effects especially in human beings.

Hansen AP, Lundbaek K.

Diabete Metab. 1976 Dec;2(4):203-18. Review.

PMID:
190058
12.

[Role of somatostatin in the diabetic].

Basdevant A.

Nouv Presse Med. 1977 Mar 12;6(10):841-5. Review. French. No abstract available.

PMID:
322089
13.

Somatostatin. Physiology and clinical applications.

Gerich JE, Patton GS.

Med Clin North Am. 1978 Mar;62(2):375-92. Review. No abstract available.

PMID:
347198
14.

Somatostatin (growth hormone-release inhibiting hormone).

Gomez-Pan A, Hall R.

Clin Endocrinol Metab. 1977 Mar;6(1):181-200. Review. No abstract available.

PMID:
196795
15.

[Somatostatin: its physiological importance and use in the internal disease clinic (a review of the literature)].

Alekseev IuP.

Probl Endokrinol (Mosk). 1977 Nov-Dec;23(6):93-106. Review. Russian. No abstract available.

PMID:
341118
16.

Extrahypophyseal effects of somatostatin.

Efendić S, Lins PE, Uvnäs-Wallensten K.

Ann Clin Res. 1978;10(3):151-6. Review.

PMID:
363038
17.

Pituitary actions of somatostatin.

Snow MH, Scanlon MF, Mora B, Heath M, Hall R, Gomez-Pan A.

Ann Clin Res. 1978;10(3):145-50. Review. No abstract available.

PMID:
214011
18.

Somatostatin (second of two parts).

Reichlin S.

N Engl J Med. 1983 Dec 22;309(25):1556-63. Review. No abstract available.

PMID:
6140639
19.

The role of glucagon in the endogenous hyperglycemia of diabetes mellitus.

Unger RH, Orci L.

Annu Rev Med. 1977;28:119-30. Review. No abstract available.

PMID:
324351
20.

Somatostatin and the gastrointestinal secretions.

Konturek SJ.

Scand J Gastroenterol. 1976;11(1):1-4. Review. No abstract available.

PMID:
766152

Supplemental Content

Support Center